VC-backed Harpoon Therapeutics appoints McMahon as president and CEO

MPM Capital-backed Harpoon Therapeutics Inc, which is developing antibody therapies to treat cancer patients, has appointed Dr. Gerald McMahon as president and CEO. Previously, McMahon worked at Kolltan Pharmaceuticals where he served as president and CEO.

13 December 2016•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail